Glomerular filtration rate estimated using serum creatinine and cystatin c, and Creatinine Cleareance measured in COPD patients. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019
Obstructive sleep apnea and the risk of chronic kidney disease – glomerular filtration rate estimations based on serum cystatin C and creatinine concentrations Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Association between estimated Glomerular Filtration Rate (eGFR) and cardiovascular risk in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017
Glomerular filtration rate is a confounder for determination of serum soluble mesothelin Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Sildenafil (SIL) reduces serum creatinine (SCr) in patients with pulmonary arterial hypertension (PAH): Relationship to clinical outcomes Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011
Pulmonary hypertension (PH) in end-stage renal (ESRD) patients receiving dialysis: prevalence and clinical significance Source: Eur Respir J 2007; 30: Suppl. 51, 345s Year: 2007
Microalbuminuria in patients with COPD: prevalence and correlations with pulmonary parameters Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Mucocilary clearance of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Estimated glomerular filtration rate (eGFR) changes after obstructive sleep apnea (OSA) treatment by positive airway pressure: data from the European Sleep Apnea Database (ESADA) Source: International Congress 2017 – CPAP therapy Year: 2017
Heart rate variability, nocturnal hypoxemia and C-reactive protein in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - COPD and comorbidity Year: 2007
Heart rate variability in patients with asthma and symptomatic hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 478s Year: 2003
Estimation of VO2 max through heart rate ratios method in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 498s Year: 2005
The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018
Stable state fibrinogen is additive to MR-proADM as a predictor of mortality in COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020
FEV1 /Height2 could be a better alternative than FEV1 in predicting all cause mortality in patients with COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
Procalcitonin and proadrenomedullin in COPD patients: Stable state versus exacerbation difference in mortality rate? Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012
Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014
Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019 Year: 2019
COPD patients with more severe GOLD stages have higher serum cystatin C levels Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012